Drawing for THEOREMA

USPTO serial 99946330

THEOREMA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
—
Law office
—

What this means

Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.

Status 630: Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies.

Need help with THEOREMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ben Natter

Ben Natter Haug Partners, LLP745 Fifth AvenueNew York, NY 10151United States

Goods and services

ClassDescriptionStatusFirst use
035Business consulting services in the fields of life sciences, biotechnology, pharmaceuticals, chemistry, materials science, and related scientific disciplines; business development consulting services; business advisory services relating to the acquisition, licensing, commercialization, and management of scientific, pharmaceutical, biotechnology, and technology assets; business evaluation of scientific, pharmaceutical, biotechnology, and technology assets; matching buyers and sellers of scientific, pharmaceutical, biotechnology, and technology assets; business research and analysis relating to licensing opportunities, asset sourcing, asset acquisition, and commercialization strategies; providing business information and business intelligence relating to scientific, pharmaceutical, biotechnology, and technology marketsACTIVE—
042Software as a service (SaaS) services featuring software that utilizes artificial intelligence for scientific research, literature review, data analysis, hypothesis generation, and research workflow automation; providing temporary use of online non-downloadable software for analyzing scientific and technical data, generating research insights, and supporting research and development activities; scientific research and development services; scientific consulting services in the fields of life sciences, biotechnology, pharmaceuticals, chemistry, materials science, and related scientific disciplines; conducting scientific evaluations, analyses, and assessments relating to target discovery, biomarker discovery, translational research, scientific research prioritization, scientific asset evaluation, patent clearance, intellectual property assessments, exclusivity analyses, regulatory strategy, and submission readiness; technical due diligence services relating to scientific, pharmaceutical, biotechnology, and technology assets; research and development of pharmaceutical, biotechnological, chemical, and materials science technologies, products, compounds, molecules, and intellectual property assetsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 17, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 17, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance